2rcx

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="2rcx" size="350" color="white" frame="true" align="right" spinBox="true" caption="2rcx, resolution 2.000&Aring;" /> '''AmpC Beta-lactamase...)
Line 4: Line 4:
==Overview==
==Overview==
-
Boronic acids have proved to be promising selective inhibitors of, beta-lactamases, acting as transition state analogues. Starting from a, previously described nanomolar inhibitor of AmpC beta-lactamase, three new, inhibitors were designed to gain interactions with highly conserved, residues, such as Asn343, and to bind more tightly to the enzyme. Among, these, one was obtained by stereoselective synthesis and succeeded in, placing its anionic group into the carboxylate binding site of the enzyme, as revealed by X-ray crystallography of the complex inhibitor/AmpC., Nevertheless, it failed at improving affinity, when compared to the lead, from which it was derived. The origins of this structural and energetic, discrepancy are discussed.
+
Boronic acids have proved to be promising selective inhibitors of beta-lactamases, acting as transition state analogues. Starting from a previously described nanomolar inhibitor of AmpC beta-lactamase, three new inhibitors were designed to gain interactions with highly conserved residues, such as Asn343, and to bind more tightly to the enzyme. Among these, one was obtained by stereoselective synthesis and succeeded in placing its anionic group into the carboxylate binding site of the enzyme, as revealed by X-ray crystallography of the complex inhibitor/AmpC. Nevertheless, it failed at improving affinity, when compared to the lead from which it was derived. The origins of this structural and energetic discrepancy are discussed.
==About this Structure==
==About this Structure==
Line 17: Line 17:
[[Category: Morandi, S.]]
[[Category: Morandi, S.]]
[[Category: Prati, F.]]
[[Category: Prati, F.]]
-
[[Category: Shoichet, B.K.]]
+
[[Category: Shoichet, B K.]]
[[Category: PO4]]
[[Category: PO4]]
[[Category: SM4]]
[[Category: SM4]]
Line 27: Line 27:
[[Category: serine hydrolase]]
[[Category: serine hydrolase]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jan 23 11:59:46 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 18:46:15 2008''

Revision as of 16:46, 21 February 2008


2rcx, resolution 2.000Å

Drag the structure with the mouse to rotate

AmpC Beta-lactamase in complex with (1R)-1-(2-Thiophen-2-yl-acetylamino)-1-(3-(2-carboxyvinyl)-phenyl) methylboronic acid

Overview

Boronic acids have proved to be promising selective inhibitors of beta-lactamases, acting as transition state analogues. Starting from a previously described nanomolar inhibitor of AmpC beta-lactamase, three new inhibitors were designed to gain interactions with highly conserved residues, such as Asn343, and to bind more tightly to the enzyme. Among these, one was obtained by stereoselective synthesis and succeeded in placing its anionic group into the carboxylate binding site of the enzyme, as revealed by X-ray crystallography of the complex inhibitor/AmpC. Nevertheless, it failed at improving affinity, when compared to the lead from which it was derived. The origins of this structural and energetic discrepancy are discussed.

About this Structure

2RCX is a Single protein structure of sequence from Escherichia coli with and as ligands. Active as Beta-lactamase, with EC number 3.5.2.6 Full crystallographic information is available from OCA.

Reference

Structure-based optimization of cephalothin-analogue boronic acids as beta-lactamase inhibitors., Morandi S, Morandi F, Caselli E, Shoichet BK, Prati F, Bioorg Med Chem. 2007 Nov 6;. PMID:17997318

Page seeded by OCA on Thu Feb 21 18:46:15 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools